Deyao Wu

1.0k total citations
19 papers, 748 citations indexed

About

Deyao Wu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Deyao Wu has authored 19 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Deyao Wu's work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (8 papers). Deyao Wu is often cited by papers focused on MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (8 papers). Deyao Wu collaborates with scholars based in China. Deyao Wu's co-authors include Ping Qü, Yunfeng Zhou, Jun Tao, HUIXING PAN, Jian Zhou, Bin Xu, Wei Zhang, Ninghan Feng, Hongfei Wu and Lixin Hua and has published in prestigious journals such as Urology, Molecular and Cellular Biochemistry and The Prostate.

In The Last Decade

Deyao Wu

19 papers receiving 740 citations

Peers

Deyao Wu
Chengcheng Ren China
Elena Jelezcova United States
You Shuai China
Kei Ihira Japan
Markéta Bednaříková Czechia
Mingli Han China
Roberto Cirombella Italy
Jianning Song China
Zhixiang Zhuang China
Xinchao Wu China
Chengcheng Ren China
Deyao Wu
Citations per year, relative to Deyao Wu Deyao Wu (= 1×) peers Chengcheng Ren

Countries citing papers authored by Deyao Wu

Since Specialization
Citations

This map shows the geographic impact of Deyao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyao Wu more than expected).

Fields of papers citing papers by Deyao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deyao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyao Wu. The network helps show where Deyao Wu may publish in the future.

Co-authorship network of co-authors of Deyao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Deyao Wu. A scholar is included among the top collaborators of Deyao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deyao Wu. Deyao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Wu, Deyao, Xiaobing Niu, Jun Tao, et al.. (2017). MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncology Reports. 37(6). 3502–3508. 45 indexed citations
3.
PAN, HUIXING, et al.. (2017). Clear Cell Renal Cell Carcinoma With Extensive Osseous Metaplasia: Report of a Rare Case. Urology. 105. e3–e5. 4 indexed citations
4.
PAN, HUIXING, Xiaojian Xu, Deyao Wu, et al.. (2016). Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder. Oncology Letters. 11(2). 1486–1492. 11 indexed citations
5.
Wu, Deyao, Xiaobing Niu, HUIXING PAN, et al.. (2016). Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1. Oncology Letters. 12(4). 2906–2911. 19 indexed citations
6.
Wu, Deyao, Xiaobing Niu, HUIXING PAN, et al.. (2016). MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility. Molecular Medicine Reports. 13(3). 2287–2292. 13 indexed citations
7.
Wu, Deyao, Xiaobing Niu, HUIXING PAN, et al.. (2016). MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1. Molecular Medicine Reports. 13(5). 4379–4385. 17 indexed citations
8.
Wu, Deyao, HUIXING PAN, Yunfeng Zhou, et al.. (2015). Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4. Molecular Medicine Reports. 12(5). 7059–7064. 25 indexed citations
9.
Wu, Deyao, Yunfeng Zhou, HUIXING PAN, Ping Qü, & Jian Zhou. (2014). microRNA-99a inhibits cell proliferation, colony formation ability, migration and invasion by targeting fibroblast growth factor receptor 3 in prostate cancer. Molecular Medicine Reports. 11(2). 1469–1475. 16 indexed citations
10.
Wu, Deyao, et al.. (2014). Upregulation of the B7/CD28 family member B7-H3 in bladder cancer. Oncology Letters. 9(3). 1420–1424. 9 indexed citations
11.
12.
13.
Wu, Deyao, Min Li, Linmao Wang, et al.. (2014). microRNA-145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma. Molecular Medicine Reports. 10(1). 393–398. 37 indexed citations
14.
Wu, Deyao, Jun Tao, Jingjing Ding, et al.. (2012). Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis. Molecular Medicine Reports. 7(2). 684–688. 12 indexed citations
15.
16.
Wu, Deyao, Jun Tao, Bin Xu, et al.. (2011). Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells. Urologia Internationalis. 87(1). 105–113. 17 indexed citations
17.
Wu, Deyao, Jun Tao, Bin Xu, et al.. (2011). Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells. Urologia Internationalis. 86(3). 346–354. 11 indexed citations
18.
Xu, Bin, Xiaobing Niu, Xiangxiang Zhang, et al.. (2010). miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Molecular and Cellular Biochemistry. 350(1-2). 207–213. 166 indexed citations
19.
Xu, Bin, Ninghan Feng, Jun Tao, et al.. (2009). A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo. The Prostate. 70(5). 467–472. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengcheng Ren Breakdown of academic impact, for papers by Elena Jelezcova Breakdown of academic impact, for papers by You Shuai Breakdown of academic impact, for papers by Kei Ihira Breakdown of academic impact, for papers by Markéta Bednaříková Breakdown of academic impact, for papers by Mingli Han Breakdown of academic impact, for papers by Roberto Cirombella Breakdown of academic impact, for papers by Jianning Song Breakdown of academic impact, for papers by Zhixiang Zhuang Breakdown of academic impact, for papers by Xinchao Wu
Rankless by CCL
2026